APO Research
Talk to an analyst

APO RESEARCH · REPORT

Ceritinib Capsules

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Ceritinib Capsules Industry Growth and Trends Forecast to 2032

27 December 202574 pages

Choose your research edition.

Industry ResearchCeritinib Capsules Industry Research Report 2026109 pages · $2,950 USDIndustry Growth & TrendsGlobal Ceritinib Capsules Industry Growth and Trends Forecast to 203274 pages · $3,450 USDMarket StructureGlobal Ceritinib Capsules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032174 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ceritinib Capsules Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Ceritinib Capsules Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Ceritinib Capsules market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Ceritinib Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Ceritinib Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Ceritinib Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Ceritinib Capsules include Novartis and Jiangsu Aosaikang Pharmaceutical among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Ceritinib Capsules market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Ceritinib Capsules market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Ceritinib Capsules market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Ceritinib Capsules.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Ceritinib Capsules market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Ceritinib Capsules Market by Company

Novartis

Jiangsu Aosaikang Pharmaceutical

Ceritinib Capsules Segment by Type

150mg

450mg

Ceritinib Capsules Segment by Application

Locally Advanced NSCLC

Metastatic NSCLC

Ceritinib Capsules Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ceritinib Capsules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ceritinib Capsules and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ceritinib Capsules.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Ceritinib Capsules manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Ceritinib Capsules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 150mg Table 2. Major Company of 450mg Table 3. Global Ceritinib Capsules Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Ceritinib Capsules Sales by Type (2021-2026) & (K Units) Table 5. Global Ceritinib Capsules Sales Market Share in Volume by Type (2021-2026) Table 6. Global Ceritinib Capsules Sales by Type (2021-2026) & (US$ Million) Table 7. Global Ceritinib Capsules Sales Market Share in Value by Type (2021-2026) Table 8. Global Ceritinib Capsules Price by Type (2021-2026) & (US$/Unit) Table 9. Global Ceritinib Capsules Sales by Type (2027-2032) & (K Units) Table 10. Global Ceritinib Capsules Sales Market Share in Volume by Type (2027-2032) Table 11. Global Ceritinib Capsules Sales by Type (2027-2032) & (US$ Million) Table 12. Global Ceritinib Capsules Sales Market Share in Value by Type (2027-2032) Table 13. Global Ceritinib Capsules Price by Type (2027-2032) & (US$/Unit) Table 14. North America Ceritinib Capsules Sales by Type (2021-2026) & (K Units) Table 15. North America Ceritinib Capsules Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Ceritinib Capsules Sales by Type (2021-2026) & (K Units) Table 17. Europe Ceritinib Capsules Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Ceritinib Capsules Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Ceritinib Capsules Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Ceritinib Capsules Sales by Type (2021-2026) & (K Units) Table 21. Latin America Ceritinib Capsules Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Ceritinib Capsules Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Ceritinib Capsules Sales by Type (2021-2026) & (US$ Million) Table 24. Ceritinib Capsules Industry Trends Table 25. Ceritinib Capsules Industry Drivers Table 26. Ceritinib Capsules Industry Opportunities and Challenges Table 27. Ceritinib Capsules Industry Restraints Table 28. Global Ceritinib Capsules Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Ceritinib Capsules Revenue Market Share by Company (2021-2026) Table 30. Global Ceritinib Capsules Sales by Company (2021-2026) & (K Units) Table 31. Global Ceritinib Capsules Sales Share by Company (2021-2026) Table 32. Global Ceritinib Capsules Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Ceritinib Capsules Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Ceritinib Capsules Major Company Production Sites and Headquarters Table 35. Global Ceritinib Capsules Company, Product Type & Application Table 36. Global Ceritinib Capsules Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Ceritinib Capsules by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Ceritinib Capsules Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Ceritinib Capsules Sales by Region (2021-2026) & (K Units) Table 41. Global Ceritinib Capsules Sales Market Share in Volume by Region (2021-2026) Table 42. Global Ceritinib Capsules Sales by Region (2021-2026) & (US$ Million) Table 43. Global Ceritinib Capsules Sales Market Share in Value by Region (2021-2026) Table 44. Global Ceritinib Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Ceritinib Capsules Sales by Region (2027-2032) & (K Units) Table 46. Global Ceritinib Capsules Sales Market Share in Volume by Region (2027-2032) Table 47. Global Ceritinib Capsules Sales by Region (2027-2032) & (US$ Million) Table 48. Global Ceritinib Capsules Sales Market Share in Value by Region (2027-2032) Table 49. Global Ceritinib Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Ceritinib Capsules Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Ceritinib Capsules Sales by Application (2021-2026) & (K Units) Table 52. Global Ceritinib Capsules Sales Market Share in Volume by Application (2021-2026) Table 53. Global Ceritinib Capsules Sales by Application (2021-2026) & (US$ Million) Table 54. Global Ceritinib Capsules Sales Market Share in Value by Application (2021-2026) Table 55. Global Ceritinib Capsules Price by Application (2021-2026) & (US$/Unit) Table 56. Global Ceritinib Capsules Sales by Application (2027-2032) & (K Units) Table 57. Global Ceritinib Capsules Sales Market Share in Volume by Application (2027-2032) Table 58. Global Ceritinib Capsules Sales by Application (2027-2032) & (US$ Million) Table 59. Global Ceritinib Capsules Sales Market Share in Value by Application (2027-2032) Table 60. Global Ceritinib Capsules Price by Application (2027-2032) & (US$/Unit) Table 61. North America Ceritinib Capsules Sales by Application (2021-2026) & (K Units) Table 62. North America Ceritinib Capsules Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Ceritinib Capsules Sales by Application (2021-2026) & (K Units) Table 64. Europe Ceritinib Capsules Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Ceritinib Capsules Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Ceritinib Capsules Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Ceritinib Capsules Sales by Application (2021-2026) & (K Units) Table 68. Latin America Ceritinib Capsules Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Ceritinib Capsules Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Ceritinib Capsules Sales by Application (2021-2026) & (US$ Million) Table 71. Novartis Company Information Table 72. Novartis Business Overview Table 73. Novartis Ceritinib Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Novartis Ceritinib Capsules Product Portfolio Table 75. Novartis Recent Development Table 76. Jiangsu Aosaikang Pharmaceutical Company Information Table 77. Jiangsu Aosaikang Pharmaceutical Business Overview Table 78. Jiangsu Aosaikang Pharmaceutical Ceritinib Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Jiangsu Aosaikang Pharmaceutical Ceritinib Capsules Product Portfolio Table 80. Jiangsu Aosaikang Pharmaceutical Recent Development Table 81. North America Ceritinib Capsules Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 82. North America Ceritinib Capsules Sales by Country (2021-2026) & (K Units) Table 83. North America Ceritinib Capsules Sales Market Share by Country (2021-2026) Table 84. North America Ceritinib Capsules Sales Forecast by Country (2027-2032) & (K Units) Table 85. North America Ceritinib Capsules Sales Market Share Forecast by Country (2027-2032) Table 86. North America Ceritinib Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 87. North America Ceritinib Capsules Market Size by Country (2021-2026) & (US$ Million) Table 88. North America Ceritinib Capsules Market Share by Country (2021-2026) Table 89. North America Ceritinib Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 90. North America Ceritinib Capsules Market Share Forecast by Country (2027-2032) Table 91. Europe Ceritinib Capsules Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 92. Europe Ceritinib Capsules Sales by Country (2021-2026) & (K Units) Table 93. Europe Ceritinib Capsules Sales Market Share by Country (2021-2026) Table 94. Europe Ceritinib Capsules Sales Forecast by Country (2027-2032) & (K Units) Table 95. Europe Ceritinib Capsules Sales Market Share Forecast by Country (2027-2032) Table 96. Europe Ceritinib Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 97. Europe Ceritinib Capsules Market Size by Country (2021-2026) & (US$ Million) Table 98. Europe Ceritinib Capsules Market Share by Country (2021-2026) Table 99. Europe Ceritinib Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 100. Europe Ceritinib Capsules Market Share Forecast by Country (2027-2032) Table 101. Asia-Pacific Ceritinib Capsules Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 102. Asia-Pacific Ceritinib Capsules Sales by Country (2021-2026) & (K Units) Table 103. Asia-Pacific Ceritinib Capsules Sales Market Share by Country (2021-2026) Table 104. Asia-Pacific Ceritinib Capsules Sales Forecast by Country (2027-2032) & (K Units) Table 105. Asia-Pacific Ceritinib Capsules Sales Market Share Forecast by Country (2027-2032) Table 106. Asia-Pacific Ceritinib Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 107. Asia-Pacific Ceritinib Capsules Market Size by Country (2021-2026) & (US$ Million) Table 108. Asia-Pacific Ceritinib Capsules Market Share by Country (2021-2026) Table 109. Asia-Pacific Ceritinib Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 110. Asia-Pacific Ceritinib Capsules Market Share Forecast by Country (2027-2032) Table 111. Latin America Ceritinib Capsules Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 112. Latin America Ceritinib Capsules Sales by Country (2021-2026) & (K Units) Table 113. Latin America Ceritinib Capsules Sales Market Share by Country (2021-2026) Table 114. Latin America Ceritinib Capsules Sales Forecast by Country (2027-2032) & (K Units) Table 115. Latin America Ceritinib Capsules Sales Market Share Forecast by Country (2027-2032) Table 116. Latin America Ceritinib Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. Latin America Ceritinib Capsules Market Size by Country (2021-2026) & (US$ Million) Table 118. Latin America Ceritinib Capsules Market Share by Country (2021-2026) Table 119. Latin America Ceritinib Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. Latin America Ceritinib Capsules Market Share Forecast by Country (2027-2032) Table 121. Middle East and Africa Ceritinib Capsules Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 122. Middle East and Africa Ceritinib Capsules Sales by Country (2021-2026) & (K Units) Table 123. Middle East and Africa Ceritinib Capsules Sales Market Share by Country (2021-2026) Table 124. Middle East and Africa Ceritinib Capsules Sales Forecast by Country (2027-2032) & (K Units) Table 125. Middle East and Africa Ceritinib Capsules Sales Market Share Forecast by Country (2027-2032) Table 126. Middle East and Africa Ceritinib Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Middle East and Africa Ceritinib Capsules Market Size by Country (2021-2026) & (US$ Million) Table 128. Middle East and Africa Ceritinib Capsules Market Share by Country (2021-2026) Table 129. Middle East and Africa Ceritinib Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Middle East and Africa Ceritinib Capsules Market Share Forecast by Country (2027-2032) Table 131. Key Raw Materials Table 132. Raw Materials Key Suppliers Table 133. Ceritinib Capsules Distributors List Table 134. Ceritinib Capsules Customers List Table 135. Research Programs/Design for This Report Table 136. Authors List of This Report Table 137. Secondary Sources Table 138. Primary Sources List of Figures Figure 1. Ceritinib Capsules Image Figure 2. Global Ceritinib Capsules Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ceritinib Capsules Market Size (2021-2032) & (US$ Million) Figure 4. Global Ceritinib Capsules Sales (2021-2032) & (K Units) Figure 5. 150mg Image Figure 6. Global 150mg Sales YoY Growth (2021-2032) & (K Units) Figure 7. 450mg Image Figure 8. Global 450mg Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Ceritinib Capsules Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Ceritinib Capsules Market Share by Type 2025 VS 2032 Figure 11. North America Ceritinib Capsules Sales Market Share in Volume by Type in 2025 Figure 12. North America Ceritinib Capsules Sales Market Share in Value by Type in 2025 Figure 13. Europe Ceritinib Capsules Sales Market Share in Volume by Type in 2025 Figure 14. Europe Ceritinib Capsules Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Ceritinib Capsules Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Ceritinib Capsules Sales Market Share in Value by Type in 2025 Figure 17. Latin America Ceritinib Capsules Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Ceritinib Capsules Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Ceritinib Capsules Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Ceritinib Capsules Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Ceritinib Capsules Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Locally Advanced NSCLC Image Figure 24. Global Locally Advanced NSCLC Sales YoY Growth (2021-2032) & (K Units) Figure 25. Metastatic NSCLC Image Figure 26. Global Metastatic NSCLC Sales YoY Growth (2021-2032) & (K Units) Figure 27. Global Ceritinib Capsules Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Ceritinib Capsules Market Share by Application 2025 VS 2032 Figure 29. North America Ceritinib Capsules Sales Market Share in Volume by Application in 2025 Figure 30. North America Ceritinib Capsules Sales Market Share in Value by Application in 2025 Figure 31. Europe Ceritinib Capsules Sales Market Share in Volume by Application in 2025 Figure 32. Europe Ceritinib Capsules Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Ceritinib Capsules Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Ceritinib Capsules Sales Market Share in Value by Application in 2025 Figure 35. Latin America Ceritinib Capsules Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Ceritinib Capsules Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Ceritinib Capsules Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Ceritinib Capsules Sales Market Share in Value by Application in 2025 Figure 39. North America Ceritinib Capsules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 40. North America Ceritinib Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Ceritinib Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Ceritinib Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Ceritinib Capsules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. Europe Ceritinib Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Ceritinib Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Ceritinib Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Ceritinib Capsules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Asia-Pacific Ceritinib Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Ceritinib Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Ceritinib Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Ceritinib Capsules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Latin America Ceritinib Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Ceritinib Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Ceritinib Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Ceritinib Capsules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Middle East and Africa Ceritinib Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Ceritinib Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Ceritinib Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Ceritinib Capsules Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Ceritinib Capsules Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • 150mg
  • 450mg
Applications
  • Locally Advanced NSCLC
  • Metastatic NSCLC
Companies covered
  • Novartis
  • Jiangsu Aosaikang Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Ceritinib Capsules Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Ceritinib Capsules Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Ceritinib Capsules Market by Type
  6. 1.3.1 150mg
  7. 1.3.2 450mg
  8. 1.4 Global Ceritinib Capsules Market Size by Type
  9. 1.4.1 Global Ceritinib Capsules Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Ceritinib Capsules Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Ceritinib Capsules Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Ceritinib Capsules Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Ceritinib Capsules Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Ceritinib Capsules Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Ceritinib Capsules Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Ceritinib Capsules Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Ceritinib Capsules Industry Trends
  2. 2.2 Ceritinib Capsules Industry Drivers
  3. 2.3 Ceritinib Capsules Industry Opportunities and Challenges
  4. 2.4 Ceritinib Capsules Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Ceritinib Capsules Revenue (2021-2026)
  2. 3.2 Global Top Players by Ceritinib Capsules Sales (2021-2026)
  3. 3.3 Global Top Players by Ceritinib Capsules Price (2021-2026)
  4. 3.4 Global Ceritinib Capsules Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Ceritinib Capsules Major Company Production Sites & Headquarters
  6. 3.6 Global Ceritinib Capsules Company, Product Type & Application
  7. 3.7 Global Ceritinib Capsules Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Ceritinib Capsules Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Ceritinib Capsules Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Ceritinib Capsules Tier 1, Tier 2, and Tier 3
4 Ceritinib Capsules Regional Status and Outlook
  1. 4.1 Global Ceritinib Capsules Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Ceritinib Capsules Historic Market Size by Region
  3. 4.2.1 Global Ceritinib Capsules Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Ceritinib Capsules Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Ceritinib Capsules Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Ceritinib Capsules Forecasted Market Size by Region
  7. 4.3.1 Global Ceritinib Capsules Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Ceritinib Capsules Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Ceritinib Capsules Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Ceritinib Capsules by Application
  1. 5.1 Ceritinib Capsules Market by Application
  2. 5.1.1 Locally Advanced NSCLC
  3. 5.1.2 Metastatic NSCLC
  4. 5.2 Global Ceritinib Capsules Market Size by Application
  5. 5.2.1 Global Ceritinib Capsules Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Ceritinib Capsules Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Ceritinib Capsules Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Ceritinib Capsules Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Ceritinib Capsules Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Ceritinib Capsules Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Ceritinib Capsules Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Ceritinib Capsules Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Novartis
  2. 6.1.1 Novartis Company Information
  3. 6.1.2 Novartis Business Overview
  4. 6.1.3 Novartis Ceritinib Capsules Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Novartis Ceritinib Capsules Product Portfolio
  6. 6.1.5 Novartis Recent Developments
  7. 6.2 Jiangsu Aosaikang Pharmaceutical
  8. 6.2.1 Jiangsu Aosaikang Pharmaceutical Company Information
  9. 6.2.2 Jiangsu Aosaikang Pharmaceutical Business Overview
  10. 6.2.3 Jiangsu Aosaikang Pharmaceutical Ceritinib Capsules Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Jiangsu Aosaikang Pharmaceutical Ceritinib Capsules Product Portfolio
  12. 6.2.5 Jiangsu Aosaikang Pharmaceutical Recent Developments
7 North America by Country
  1. 7.1 North America Ceritinib Capsules Sales by Country
  2. 7.1.1 North America Ceritinib Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Ceritinib Capsules Sales by Country (2021-2026)
  4. 7.1.3 North America Ceritinib Capsules Sales Forecast by Country (2027-2032)
  5. 7.2 North America Ceritinib Capsules Market Size by Country
  6. 7.2.1 North America Ceritinib Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Ceritinib Capsules Market Size by Country (2021-2026)
  8. 7.2.3 North America Ceritinib Capsules Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Ceritinib Capsules Sales by Country
  2. 8.1.1 Europe Ceritinib Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Ceritinib Capsules Sales by Country (2021-2026)
  4. 8.1.3 Europe Ceritinib Capsules Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Ceritinib Capsules Market Size by Country
  6. 8.2.1 Europe Ceritinib Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Ceritinib Capsules Market Size by Country (2021-2026)
  8. 8.2.3 Europe Ceritinib Capsules Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Ceritinib Capsules Sales by Country
  2. 9.1.1 Asia-Pacific Ceritinib Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Ceritinib Capsules Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Ceritinib Capsules Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Ceritinib Capsules Market Size by Country
  6. 9.2.1 Asia-Pacific Ceritinib Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Ceritinib Capsules Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Ceritinib Capsules Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Ceritinib Capsules Sales by Country
  2. 10.1.1 South America Ceritinib Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Ceritinib Capsules Sales by Country (2021-2026)
  4. 10.1.3 South America Ceritinib Capsules Sales Forecast by Country (2027-2032)
  5. 10.2 South America Ceritinib Capsules Market Size by Country
  6. 10.2.1 South America Ceritinib Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Ceritinib Capsules Market Size by Country (2021-2026)
  8. 10.2.3 South America Ceritinib Capsules Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Ceritinib Capsules Sales by Country
  2. 11.1.1 Middle East and Africa Ceritinib Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Ceritinib Capsules Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Ceritinib Capsules Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Ceritinib Capsules Market Size by Country
  6. 11.2.1 Middle East and Africa Ceritinib Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Ceritinib Capsules Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Ceritinib Capsules Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Ceritinib Capsules Value Chain Analysis
  2. 12.1.1 Ceritinib Capsules Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Ceritinib Capsules Production Mode & Process
  7. 12.2 Ceritinib Capsules Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Ceritinib Capsules Distributors
  10. 12.2.3 Ceritinib Capsules Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst